Hjem › Diffust stort B-cellelymfom › North Carolina › Greenville
Kliniske studier for Diffust stort B-cellelymfom i Greenville, NC
4 studier for Diffust stort B-cellelymfom søker deltakere på steder i og rundt Greenville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekruttererFase 3
- East Carolina University ( Site 0159), Greenville
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
RekruttererFase 3
- East Carolina University, Greenville
Registry of Older Patients With Cancer
RekruttererObservasjonsstudie
- East Carolina University, Greenville
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
RekruttererFase 2
- Brody School of Medicine at East Carolina University, Greenville
Diffust stort B-cellelymfom-studier i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Milwaukee, WI16 studier
- Boston, MA16 studier
- Nashville, TN15 studier
- Philadelphia, PA15 studier
- Portland, OR15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
Andre studier i Greenville
- Akut myelogen leukemi10 studier
- Sigdcelleanemi9 studier
- Idiopatisk trombocytopenisk purpura6 studier
- Hjertesvikt6 studier
- Kronisk lymfatisk leukemi5 studier
- Burkitts lymfom5 studier
- Fedme5 studier
- Type 2-diabetes5 studier
- Blodlidelser5 studier
- Kreft (alle typer)4 studier
- Autoimmune sykdommer4 studier
- Myeloproliferative neoplasmer4 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.